Popular Diabetes and Weight-Loss Drugs May Protect Stroke Survivors from Future Attacks, Study Finds

ATTENTION ALL CUSTOMERS:
Due to a recent change in our pharmacy software system, the process for submitting refill requests online has now changed.
Our previous mobile app and your current login credentials will no longer work.
Please click the Refill Prescriptions tab to begin the new process.
Thank you for your patience during this transition.

Now offering hormone and vitality management consults!
Call 706-886-3119 for more information.

Posted November 11, 2024

New research shows GLP-1 agonists, like Ozempic, and SGLT2 inhibitors, like Farxiga, help lower the risk of secondary stroke, heart attack and death in stroke survivors.

Health News is provided as a service to Maddox Drugs site users by HealthDay. Maddox Drugs nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.

Get Healthy!